100 related articles for article (PubMed ID: 7821341)
21. Safety and efficacy of monotherapy with fantofarone, a novel calcium channel antagonist, in patients with chronic stable angina pectoris. Fantofarone Study Group.
Glasser SP; Singh SN; Humen DP
J Clin Pharmacol; 1997 Jan; 37(1):53-7. PubMed ID: 9048273
[TBL] [Abstract][Full Text] [Related]
22. Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein.
Jaffrézou JP; Herbert JM; Levade T; Gau MN; Chatelain P; Laurent G
J Biol Chem; 1991 Oct; 266(29):19858-64. PubMed ID: 1918089
[TBL] [Abstract][Full Text] [Related]
23. Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma.
Kato Y; Ozawa S; Tsukuda M; Kubota E; Miyazaki K; St-Pierre Y; Hata R
FEBS J; 2007 Jun; 274(12):3171-83. PubMed ID: 17540003
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic-pharmacodynamic model for fantofarone cardiac and brachial haemodynamic effects in healthy volunteers.
Bellissant E; Giudicelli JF
Br J Clin Pharmacol; 1999 Dec; 48(6):801-10. PubMed ID: 10594483
[TBL] [Abstract][Full Text] [Related]
25. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
[TBL] [Abstract][Full Text] [Related]
26. Voltage inactivation of Ca2+ entry and secretion associated with N- and P/Q-type but not L-type Ca2+ channels of bovine chromaffin cells.
Villarroya M; Olivares R; Ruíz A; Cano-Abad MF; de Pascual R; Lomax RB; López MG; Mayorgas I; Gandía L; García AG
J Physiol; 1999 Apr; 516 ( Pt 2)(Pt 2):421-32. PubMed ID: 10087342
[TBL] [Abstract][Full Text] [Related]
27. Evidence for multiple types of Ca2+ channels in acutely isolated hippocampal CA3 neurones of the guinea-pig.
Mogul DJ; Fox AP
J Physiol; 1991 Feb; 433():259-81. PubMed ID: 1668752
[TBL] [Abstract][Full Text] [Related]
28. Voltage-dependent modulation of L-type Ca2+ current by manidipine in guinea-pig heart cells.
Tohse N; Takeda Y; Kanno M
Eur J Pharmacol; 1993 Nov; 249(2):231-3. PubMed ID: 8287905
[TBL] [Abstract][Full Text] [Related]
29. Interaction of the calcium antagonist fantofarone with phospholipids: electrostatic effects.
Chatelain P; Matteazzi JR; Laruel R
Biochem Pharmacol; 1994 Oct; 48(7):1393-8. PubMed ID: 7945438
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the slow calcium channel binding sites for [3H]SR 33557 in rat heart sarcolemmal membranes.
Chatelain P; Beaufort P; Meysmans L; Clinet M
Mol Pharmacol; 1991 Jan; 39(1):64-71. PubMed ID: 1846221
[TBL] [Abstract][Full Text] [Related]
31. Ca2+ and Na+ permeability of high-threshold Ca2+ channels and their voltage-dependent block by Mg2+ ions in chick sensory neurones.
Carbone E; Lux HD; Carabelli V; Aicardi G; Zucker H
J Physiol; 1997 Oct; 504 ( Pt 1)(Pt 1):1-15. PubMed ID: 9350613
[TBL] [Abstract][Full Text] [Related]
32. Dihydropyridine receptors functioning as voltage sensors in cardiac myocytes.
Mackiewicz U; Emanuel K; Lewartowski B
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 2):777-98. PubMed ID: 11220488
[TBL] [Abstract][Full Text] [Related]
33. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
Bezprozvanny I; Tsien RW
Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
[TBL] [Abstract][Full Text] [Related]
34. A novel class of calcium-entry blockers: the 1[[4-(aminoalkoxy)phenyl]sulfonyl]indolizines.
Gubin J; Lucchetti J; Mahaux J; Nisato D; Rosseels G; Clinet M; Polster P; Chatelain P
J Med Chem; 1992 Mar; 35(6):981-8. PubMed ID: 1552511
[TBL] [Abstract][Full Text] [Related]
35. Binding of fantofarone, a novel Ca2+ antagonist, to serum albumin: a fluorescence study.
Chatelain P; Matteazzi JR; Laruel R
J Pharm Sci; 1994 May; 83(5):674-6. PubMed ID: 8071819
[TBL] [Abstract][Full Text] [Related]
36. Effects of a novel, potent benzothiazepine Ca2+ channel antagonist, DTZ323, on guinea-pig ventricular myocytes.
Kurokawa J; Adachi-Akahane S; Nagao T
Eur J Pharmacol; 1997 May; 325(2-3):229-36. PubMed ID: 9163570
[TBL] [Abstract][Full Text] [Related]
37. Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine.
Furukawa T; Nukada T; Suzuki K; Fujita Y; Mori Y; Nishimura M; Yamanaka M
Br J Pharmacol; 1997 Jul; 121(6):1136-40. PubMed ID: 9249249
[TBL] [Abstract][Full Text] [Related]
38. Electrophysiological properties of neonatal mouse cardiac myocytes in primary culture.
Nuss HB; Marban E
J Physiol; 1994 Sep; 479 ( Pt 2)(Pt 2):265-79. PubMed ID: 7799226
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
Kenny BA; Fraser S; Spedding M
Br J Pharmacol; 1993 Jan; 108(1):93-9. PubMed ID: 7679034
[TBL] [Abstract][Full Text] [Related]
40. Ca(2+)-dependent inactivation of cardiac L-type Ca2+ channels does not affect their voltage sensor.
Shirokov R; Levis R; Shirokova N; Ríos E
J Gen Physiol; 1993 Dec; 102(6):1005-30. PubMed ID: 8133239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
